Prevention of venous thromboembolism after ischemic stroke

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 5, 2008, Pages 389-396

  Kase, Carlos S ^a,c   Pineo, Graham F ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Acute ischemic stroke; Low molecular weight heparin; Unfractionated heparin; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CERTOPARIN; DANAPAROID; DIPYRIDAMOLE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; TICLOPIDINE; FIBRINOLYTIC AGENT;

AGING; ANTICOAGULANT THERAPY; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG FATALITY; DRUG TREATMENT FAILURE; HUMAN; LIMB WEAKNESS; LUNG EMBOLISM; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; STROKE; THROMBOSIS PREVENTION; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; RISK FACTOR;

FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; RISK FACTORS; STROKE; VENOUS THROMBOEMBOLISM;

EID: 53149136259     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328307ee24     Document Type: Review

References (37)

1. Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: literature review and implications for clinical practice. Arch Phys Med Rehabil 1992; 73:S379-S391.
2. Elias A, Milandre L, Lagrange G, et al. Prevention of deep vein thrombosis of the leg by very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients). Rev Med Interne 1990; 11:95-98.
3. Sandset PM, Dahl T, Stiris M, et al. A double-blind and randomized placebo-controlled trial of low-molecular weight heparin once daily to prevent deepvein thrombosis in acute ischemic stroke. Semin Thromb Hemost 1990; 16 (Suppl):25-33.
4. Kelly J, Rudd A, Lewis RR, et al. Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 2004; 35:2320-2325.
5. Pambianco G, Orchard T, Landau P. Deep vein thrombosis: prevention in stroke patients during rehabilitation. Arch Phys Med Rehabil 1995; 76:324-330.
6. Turpie AG, Levine MN, Hirsh J, et al. Double-blind randomised trial of ORG 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet 1987; 1:523-526.
7. Warlow C, Ogston D, Douglas AS. Deep vein thrombosis of the legs after strokes. Br Med J 1976; 1:1178-1183.
8. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: The German Stroke Registers Study Group. Arch Intern Med 2004; 164:1761-1768.
9. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke 1981; 12:474-477.
10. Brown M, Glassenberg M. Mortality factors in patients with acute stroke. JAMA 1973; 224:1493-1495.
11. Viitanen M, Winblad B, Asplund K. Autopsy-verified causes of death after stroke. Acta Med Scand 1987; 222:401-408.
12. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85-e151.
13. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke 2001; 32:262-267.
14. Muir KW, Watt A, Baxter G, et al. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. Quart J Med 2000; 93:359-364.
15. Prasad BK, Banerjee AK, Howard H. Incidence of deep vein thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegics. Age Ageing 1982; 11:42-44.
16. Mazzone C, Chiodo Grandi F, Sandercock P, et al. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 2004; (4):CD001922. doi: 10.1002/14651858.CD001922.pub2.
17. André C, de FreitasGR, Fukujima MM. Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles. Eur J Neurol 2007; 14:21-32.
18. McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing 1986; 15:84-88.
19. Sandercock PA, van den Belt AG, Lindley RI, Slattery J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry 1993; 56:17-25.
20. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349:1569-1581.
21. Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2003; (2):CD000029. doi: 10.1002/14651858.CD000029.
22. Bath PMW, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke 2000; 31:1770-1778.
23. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res 2007; 119:265-274.
24. Hillbom M, ErilaT, Sotaniemi K, et al. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand 2002; 106:84-92.
25. Sherman DG, Albers GW, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet 2007; 369:1347-1355.
26. Diener H-C, Ringelstein EB, von Kummer R, et al. Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT trial. Stroke 2006; 37:139-144.
27. Dumas R, Woitinas F, Kutnowski M, et al. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Age Ageing 1 994; 23:51 2-516.
28. Turpie AG, Gent M, Cote R, et al. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke: a randomized, double-blind study. Ann Intern Med 1992; 117:353-357.
29. Kamphuisen PW, Agnelli G, Sebastianelli M. Prevention of venous thromboembolism after acute ischemic stroke. J Thromb Haemost 2005; 3:1187-1194.
30. Pineo GF, Albers GW, Bladin C, et al. Enoxaparin versus unfractionated heparin for venous thromboembolism (VTE) prophylaxis in acute ischemic stroke patients [abstract]. J Thromb Haemost 2007; 5(Suppl 2):P-T-669.
31. Leizorovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation 2004; 110 (Suppl IV):IV-13- IV-19.
32. Mismetti P, Liotier J, Kleber F-X, et al. Use of enoxaparin versus unfractionated heparin in the prevention of venous thromboembolic events in acutely ill medical patients: a meta-analysis of individual patient data [abstract]. Blood 2007; 110:1859.
33. Shorr AF, Jackson WL, Sherner JH, Moores LK. Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis. Chest 2008; 133:149-155.
34. O'Donnell M, Kearon C. Thromboembolism prevention in ischaemic stroke [editorial]. Lancet 2007; 369:1413-1415.
35. Philbrick JT, Becker DM. Calf deep venous thrombosis: a wolf in sheep's clothing. Arch Intern Med 1988; 148:2131-2138.
36. Doyle DJ, Turpie AG, Hirsh J. Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. Ann Intern Med 1987; 107:441-445.
37. Vaitkus PT, Leizorovicz A, Cohen AT, et al. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005; 93:76-79.